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Available online 11 December 2016Phage therapy is an oldmethod of combating bacterial pathogens that has recently been taken into consideration
due to the alarming spread of antibiotic resistance. Escherichia coli O157:H7 is a foodborne pathogen that causes
hemorrhagic colitis and life-threatening Hemolytic Uremic Syndrome (HUS). There are several studies on isola-
tion of speciﬁc phages against E. coli O157:H7 and more than 60 speciﬁc phages have been published so far. Al-
though in vitro experiments have been successful in elimination or reduction of E. coli O157:H7numbers, in vivo
experiments have not been as promising. This may be due to escape of bacteria to locations where phages have
difﬁculties to enter or due to the adverse conditions in the gastrointestinal tract that affect phage viability and
proliferation. To get around the latter obstacle, an alternative phage delivery method such as polymer microen-
capsulation should be tried. While the present time results are not very encouraging the work should be contin-
ued as more efﬁcient phage treatment regimens might be found in future.
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Although ﬁrst indications of bacteriophages (bacterial viruses) were
reported already in 1896 (Hankin, 1896), bacteriophageswereﬁrst timey and Immunology, Medicum,
elsinki, Helsinki, Finland.
).isolated in early 1900's (d'Herelle, 1917; Twort, 1915). Phages were
used to treat infectious diseases in different parts of the world until
late 1930s. The advent of antibiotics, improper use of phages and unsta-
ble formulations of phage particles reduced the use of phage therapy es-
pecially in Western countries (Bradbury, 2004). In recent years, the
emergence of antibiotic resistance in bacterial populations has encour-
aged researchers to ﬁnd bacteriophages to combat bacterial infections
(Deresinski, 2009).
53S. Sabouri et al. / International Journal of Food Microbiology 243 (2017) 52–57Escherichia coli O157:H7 that is present in the normal ﬂora of live-
stock (Paton and Paton, 1998) can cause hemorrhagic colitis and life-
threatening HUS (Hemolytic Uremic Syndrome). Outbreaks of this
pathogen can originate from meat, milk, vegetables and water (Ferens
and Hovde, 2011). There is a controversy about using antibiotics in
treatment of E. coli O157:H7 infections as it is believed that use of cer-
tain antibiotics could induce the release of shiga toxins (Galland et al.,
2001). Clinical studies have demonstrated that antibiotic treatment
can indeed increase the risk of HUS development (Wong et al., 2012).
In addition, antibiotic resistance among E. coli O157 isolates has in-
creased. In one study, 21% of human clinical isolates of E. coli O157
were resistant to ampicillin, 12% to sulfamethoxazole, 15% to cephalo-
thin, 12% to tetracycline, and 5% to trimethoprim-sulfamethoxazole
(Schroeder et al., 2002).
Speciﬁc phages for Escherichia coli O157:H7 can be suitable candi-
dates either for infection prevention or treatment of infected people.
2. E. coli O157 phages
More than 60 phages speciﬁc for E. coliO157:H7 have been reported
(Table 1).Most of these phages (27) belong toMyoviridae family. Eleven
phages belong to Siphoviridae and only 3 phages are from Podoviridae
family. The remaining phages have not been classiﬁed yet. Sixteen of
these phages have full genomic sequences submitted to NCBI.
3. Prevention of infection
Numbers of E. coliO157:H7 bacteria can be reduced by application of
phages on surfaces or addition of phages to animal hides or bodies. This
can decrease the numbers of bacteria in foodstuffs and thereby prevent
human infections. Experimental in vitro studies to reduce bacterial
numbers on surfaces by the use of anti-O157:H7 phages are presented
in Table 1 and discussed below.
3.1. Application of phages on surfaces and to foodstuffs
Several studies have demonstrated the usefulness of phage applica-
tion on post-slaughter meat, on working surfaces and to vegetables
(Table 1).
A phage cocktail of pp01, e11/2, and e4/1c phages eliminated efﬁ-
ciently E. coli O157 from meat when incubated at 37 °C. For this,
2 × 102 E. coli cells were spotted on meat portions. After an hr,
2 × 108 PFU phage particles were spotted onto it (O'Flynn et al.,
2004). Hong et al. also used a cocktail of 3 phages (FFH1, FFH2, and
FFH3) at multiplicity of infection (MOI) of 1 on contaminated ground
beef, spinach and cheese contaminated with 107 CFU/mL E. coli
O157:H7 bacteria. The results showed that the treatment was effective
in reducing bacterial numbers in meat by almost 2 logs and in spinach
by over 3 logs when stored 24 h at room temperature, but not in cheese
(Hong et al., 2014).
Stainless steel couponswere immersed in 30mL of 108 CFU/mL of E.
coli O157 suspension, and the coupons with an average of 4 × 102 CFU
attached cells were then immersed in a phage KH1 suspension of
5 × 107 PFU/mL. This approach reduced the numbers of E. coli by 1.2
logs during a 1 day exposure (Sharma et al., 2005). Viazis et al. tested
a cocktail of 8 phages (38, 39, 41, AR1, 42, CEV2, ECB7, ECA1) on stain-
less steel, ceramic tile, and polyethylene chips. The treatment could sig-
niﬁcantly reduce bacterial concentrations on these surfaces. They also
treated spinach and lettuce with the cocktail alone and in combination
with trans-cinnamaldehyde. Although the cocktail was effective in re-
ducing E. coli O157:H7 counts on vegetables, the combination was
muchmore effective and killed bacteria completely. These experiments
were carried out by spotting 106 PFU phage cocktail on the dried E. coli
O157:H7 spots with 104–106 CFU (Viazis et al., 2011a, 2011b). The
contaminated stainless steel, ceramic and plastic sheets were treated
with phage PhaxI and showed that the treatment reduced the E. coliO157 contamination by 95–98% (Table 1). PhaxI also killed E. coli
O157 in milk during a 90 minute incubation (Shahrbabak et al., 2013).
Magnone et al. used EcoShield, SalmoFresh, and ShigActive to con-
trol E. coliO157:H7, Salmonella, and Shigella spp. on fresh fruits and veg-
etables (Magnone et al., 2013). Ecoshield™ (ECP-100) is a FDA-cleared
commercial phage cocktail of ECML-4, ECML-117, and ECML-134 bacte-
riophages and it is used to eliminate or reduce food contamination of E.
coli O157:H7 (Carter et al., 2012; Ferguson et al., 2013). Spraying
EcoShield (1 × 106 to 5 × 106 PFU/g) reduced E. coli numbers by 94%
and 87% in beef and lettuce with an E. coli contamination of about
103 CFU/g, respectively, during a 5 min contact time (Carter et al.,
2012). Boyacioglu achieved a ca. 2.5 log CFU/cm2 reduction of bacterial
numbers (4.5 log CFU/cm2) on lettuce and spinach by spraying
EcoShield (3 × 106 PFU/cm2) together with a modiﬁed atmosphere
packaging (Boyacioglu et al., 2013). Spray application of EcoShield
with high phage concentrations (1010 and 109 PFU/mL) signiﬁcantly re-
duced E. coli numbers in contaminated hard surfaces and different food
samples (Abuladze et al., 2008). Immersion of lettuce in 6 × 109 PFU/mL
EcoShield for 2min followed by spot inoculationwith 1.2 × 105 CFU/mL
(2.5 × 102 CFU/cm2) of E. coli O157:H7 was signiﬁcantly effective in re-
duction of the pathogen. However, the low titer phage suspension
(2 × 108 PFU/mL) was not as effective. Spraying 2 × 109 PFU/mL
EcoShield after inoculation of 8 × 106 CFU/mL E. coli O157:H7 was
even more effective than immersion (Ferguson et al., 2013). EcoShield
(108 PFU/cm2) was also effective in reducing bacterial numbers on
fresh-cut cantaloupes (pipetted phage) and lettuce (sprayed phage) at
4 °C inoculated with 6 × 103 CFU/cm2 E. coli O157:H7 (Sharma et al.,
2009). A cocktail of six E. coli O157 speciﬁc phages isolated from feedlot
by Callaway and coworkers were used by spraying 50mL of 108 PFU/mL
suspension on spinach harvester blades contaminated with 7 × 104 E.
coliO157bacteria; this treatmentwas able to kill bacteria on blades dur-
ing a 2 h incubation (Patel et al., 2011).
In all studies, the anti-O157:H7 coliphages were effective in elimi-
nating or reducing contamination by this pathogen on surfaces of food
and material. However, the rate of elimination was affected by the
time and temperature of the incubation and the relative numbers of E.
coli O157:H7 and the bacteriophages.
3.2. Biocontrol or pre-harvest experiments
Some studies have applied phages to control E. coli O157:H7 num-
bers in live animals or hides. Theoretically this could decrease the
spreading of the pathogen onto food and water, but it has proven to
be less efﬁcient than application of phages on surfaces and vegetables.
While it has been convincingly demonstrated that cattle functions as a
major E. coli O157:H7 reservoir, the bacterial shedding is periodic with
the maximum incidence during summer (Bach et al., 2003). Therefore,
to circumvent the potential problems caused by the erratic nature of
the pathogen shedding, many experiments were performed on animals
negative for E. coli O157:H7 in feces (Bach et al., 2003; Callaway et al.,
2008; Rozema et al., 2009).
In one study performedwith phage DC22 only an extremely highMOI
(105 PFU/CFU) could decrease the E. coli O157:H7 levels (Table 1). The
experiment was performed in Rusitec (an artiﬁcial rumen system)
where an inoculation of phage at a MOI of 105 PFU/CFU could
eliminate107 CFU of E. coli O157:H7 from the system within 4 h,
although an inoculation of the phage at the same MOI was not effective
in reducing 108 CFU of E. coli O157:H7 bacteria in sheep feces (Table 1).
Furthermore, in both treated and control lamb groups, the O157:H7
numbers had decreased signiﬁcantly after 13 days and completely
eliminated one month post inoculation (Bach et al., 2003).
Raya et al. showed that a single oral dose of phage CEV1 (~1011 PFU)
could reduce the level of E. coliO157:H7 (~1010 CFUbyoral gavage) by 2
logs in ruminal, cecal, and rectal contents of sheep, demonstrating that
in this case the phage was a promising candidate for phage therapy
(Raya et al., 2006). Raya and coworkers also reported a signiﬁcant
Table 1
Phages against Escherichia coli O157:H7used in in vivo and in vitro experiments.
Phage (family) Infection model Number of bacteria Efﬁcacy Reference
Before After
In vitro experimentsa
DC22 (Myoviridae) Artiﬁcial rumen system (Rusitec) 107 Undetectable 100% after 4 h (Bach et al., 2003)
CEV2 (Siphoviridae) Vegetables, stainless steel, ceramic,
polyethylene chips (in a cocktail)
104–106 Undetectable 100% (Viazis et al., 2011a,
2011b)
38, 39, 41, 42, ECA1, ECB7
(?)
Vegetables, stainless steel, ceramic,
polyethylene chips (in a cocktail)
104–106 Undetectable 100% (Viazis et al., 2011a,
2011b)
AR1 (Myoviridae) Vegetables, stainless steel, ceramic,
polyethylene chips (in a cocktail)
104–106 Undetectable 100% (Viazis et al., 2011a,
2011b)
KH1 (?) Stainless steel 4 × 102 4 × 101 Partial (Sharma et al., 2005)
PhaxI (Myoviridae) Milk
Stainless steel, ceramic and plastic sheet
1.5 × 105
5 × 105
Undetectable
Undetectable
Efﬁcient
Efﬁcient
(Shahrbabak et al.,
2013)
Unpublished data
pp01 (Myoviridae) Meat, combined with e11/2 and e4/1c 2 × 102 Undetectable Efﬁcient (O'Flynn et al., 2004)
e11/2 (112) (Myoviridae) Meat as above
Cattle hide
Model rumen system
2 × 102
106 CFU/cm2
103 and
106 CFU/ml
Undetectable
~104 CFU/cm2
101
Efﬁcient
Almost efﬁcient
Efﬁcient
(O'Flynn et al., 2004)
(Coffey et al., 2011)
(Rivas et al., 2010)
e4/1c (Siphoviridae) Meat as above
Cattle hide as above
Model rumen system
2 × 102
106 CFU/cm2
103 and 106
Undetectable
~104 CFU/cm2
1.5 × 102–103
Efﬁcient
Almost efﬁcient
Efﬁcient
(O'Flynn et al., 2004)
(Coffey et al., 2011)
(Rivas et al., 2010)
ECML-4, ECML-117,
ECML-134 (Myoviridae)
Hard surfaces
Vegetables,
Ground beef
Beef, lettuce
Lettuce
Lettuce, spinach
105
104
106
~103 CFU/g
2.5 × 102 CFU/cm2
3 × 104 CFU/cm2
Low
Low
Low
Less than 103
Undetectable
~102 CFU/cm2
Efﬁcient
Efﬁcient
Efﬁcient
Efﬁcient
Efﬁcient
Efﬁcient
(Abuladze et al., 2008)
(Carter et al., 2012)
(Ferguson et al., 2013)
(Boyacioglu et al., 2013)
Callaway phages (?) Stainless steel 7 × 104 Undetectable Efﬁcient (Patel et al., 2011)
FFH1, FFH3 (Siphoviridae) Ground beef, spinach
Cheese (in combination with FFH2)
107
107
~105
107
Efﬁcient
Not efﬁcient
(Hong et al., 2014)
FFH2 (Myoviridae) Ground beef, spinach
Cheese (in combination with FFH1, FFH3)
107
107
~105
107
Efﬁcient
Not efﬁcient
(Hong et al., 2014)
P2BH2, PAH6 (?) Rabbit ileal loop ~108 ~102 Efﬁcient (Alam et al., 2011)
FAHEc1 (Myoviridae) Beef 1.4 × 104 Undetectable Efﬁcient (Hudson et al., 2013)
In vivo experiments
DC22 (Myoviridae) Sheep, orally 108 Undetectable
(after 1 month)
No difference with control (Bach et al., 2003)
CEV1 (Myoviridae) Sheep, orally alone or in combination with
CEV2
~1010
1010
Less than104 (in
cecum)
~8 × 102
2–3 log more reduction compared
to control
99% alone, 99.9% cocktail
(Raya et al., 2006)
(Raya et al., 2011)
CEV2 (Siphoviridae) Sheep, orally in combination with CEV1 1010 ~8 × 102 99.9% (Raya et al., 2011)
SH1 (?) Mice, orally alone or in combination with
KH1
Steer, rectally in combination with KH1
108
106
Undetectable
2.5 × 102
Completely efﬁcient
Partially efﬁcient
(Sheng et al., 2006)
KH1 (?) Sheep, orally alone
Mice and steer in combination with SH1
3.5 × 1010
Such as SH1
Similar to
untreated
Such as SH1
Not efﬁcient
Such as SH1
(Sheng et al., 2006)
e11/2 (112) (Myoviridae) Cattle, orally in combination with e4/1c 1010 About 103 CFU/g
feces
Not efﬁcient compared to control (Rivas et al., 2010)
e4/1c (Siphoviridae) Cattle, orally in combination with e11/2 1010 About 103 CFU/g
feces
Not efﬁcient compared to control (Rivas et al., 2010)
Callaway phages (?) Sheep, orally 1010 ~104 CFU/g feces Efﬁcient compared to control (Callaway et al.,
2008)
SP21, SP22 (?) Mice, orally (cocktail with SP15) 109 Less than
102 CFU/g feces
Efﬁcient (daily phage
administration)
(Tanji et al., 2005)
SP15 (Syphoviridae) Mice, orally (cocktail with SP21 and SP22) 109 Less than
102 CFU/g feces
Efﬁcient (daily phage
administration)
(Tanji et al., 2005)
rV5, wV7, wV8, wV11
(Myoviridae)
Steer, oral and rectal 5 × 1010 102–103 CFU/g
feces (day 12)
Generally not efﬁcient compared
to non-treated control
(Rozema et al., 2009)
ФD, ФW (Myoviridae) Mice, injection alone, orally (ФD) 107 0 (for ФD), ~105
(for ФW)
Efﬁcient after 48 h (Capparelli et al.,
2006)
Phage with no reported experiments
LG1 (Myoviridae) – – – – (Goodridge et al.,
2003)
CBA65 (?) – – – – (Viazis et al., 2011a,
54 S. Sabouri et al. / International Journal of Food Microbiology 243 (2017) 52–57
Table 1 (continued)
Phage (family) Infection model Number of bacteria Efﬁcacy Reference
Before After
2011b, 2011c)
SP09 (?) – – – – (Tanji et al., 2004)
JS98 (Myoviridae) – – – – (Zuber et al., 2007)
phiKP26 (Siphoviridae) – – – – (Amarillas et al.,
2013)
EC6 (Myoviridae) – – – – (Tiwari and Kim,
2013)
a In vitro experiments using different culture media are not included.
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vage) by using a cocktail of CEV1 and CEV2 (~1011 PFU) in sheep
(Raya et al., 2011).
Administration of 1.3 × 1011 PFU of KH1 phage orally had no
signiﬁcant effect on bacterial numbers in sheep feces (Table 1).
Using high doses of phage preparations increased the phage PFU in
animal feces, but did not reduce E. coli O157 CFU. The authors
proposed that this may be related to the nature of the KH1 phage
and/or the conditions in the intestinal tract. However, treatment of
mice orally with the SH1 phage alone or in combination with KH1
(~1010 PFU), eliminated the E. coli O157:H7 bacteria from the feces
of mice infected with an oral dose of 108 CFU. A high titer cocktail
of KH1 and SH1 (~1010 PFU) used at the rectoanal junction in cattle
decreased E. coli O157:H7 CFU as well (Sheng et al., 2006).
Callaway et al. used an oral (~1010 PFU) cocktail of 8 phages isolated
from feedlot to treat sheep (Table 1). They could reduce the bacterial
counts from 107 CFU/g feces to 104 CFU/g feces, but were not able to
eliminate the pathogens completely (Callaway et al., 2008; Callaway
et al., 2006).
Using phage e11/2 atMOIs 100 and 1 in amodel rumen system inoc-
ulated with 103 or 106 CFU/mL of E. coli O157:H7 reduced signiﬁcantly
the bacterial numbers within 1 h. In the same conditions, e4/1c (MOIs
10 and 1000) reduced bacterial count within 2 h. However, oral doses
of bacteriophage cocktail of e11/2 and e4/1c (1011 PFU) repeated for
3 days could not eliminate E. coli O157 from cattle feces (Table 1). Al-
though the model rumen results for these two phages seemed promis-
ing, in vivo results were not as promising (Rivas et al., 2010). A cocktail
of e11/2 (1× 109 PFU/mL) and e4/1c (1× 1010 PFU/mL) phageswas also
tested on 400 cm2 cattle hide portions having 1 × 106 CFU/cm2 E. coli
O157:H7. The results after immediate sampling showed that this treat-
ment was not more effective than washing with water only. However,
when sampling was done after 1 h, the bacterial numbers were signiﬁ-
cantly lower (1.5 log10 CFU/cm2) than inwater washed samples (Coffey
et al., 2011).
Rozema et al. used a cocktail of four anti-O157:H7 coliphages (rV5,
wV7, wV8, wV11) orally, rectally, and in a combination of both routes
(~1011 PFU). They found that oral administration of phages was more
effective in reducing fecal shedding of E. coli O157:H7 than rectal ad-
ministration (Rozema et al., 2009). Sheng et al. reported the efﬁcacy of
rectal administration of phages to steers. They also used a concentration
of ~106 PFU/mL phages in tested animal drinking water (Sheng et al.,
2006). Rosema et al. suggested that oral administration of phages in
drinking water may be the reason of effectiveness of rectal administra-
tion of phages in the Sheng et al. paper (Rozema et al., 2009). In another
study, oral administration of a cocktail of phages SP15, SP21, and SP22
(1010 PFU, daily) in mice enhanced the rate of reduction of bacteria in
animal feces compared to groups receiving no phage and a single oral
phage dose (Table 1) (Tanji et al., 2005).
4. The bacterial surface receptors of anti-O157:H7 phages
The E. coli O157:H7 surface receptors that phages use for adsorption
have been characterized for some of the phages. LPS and the outermembrane porins are the most common receptors for phage
attachment. LPS is the receptor of the KH1, KH4, and KH5 phages,
while phages CEV1 and pp01 bind to OmpA and OmpC, respectively
(Kudva et al., 1999; Morita et al., 2002). It is proposed that OmpC and
LPS are both used by the AR1 phage (Yu et al., 2000). The E. coli ompC
mutant was resistant to phage SP21 while LPS mutants were shown to
be resistant to phage SP22 (Tanji et al., 2004). The ferrichrome-iron
receptor FhuA has been identiﬁed as the receptor for CEV2 (Raya et
al., 2011). The identiﬁcation of the phage receptors is important since
phage resistant mutants are frequently isolated. To prevent this it is
recommended to use phages with different receptors in a phage
cocktail.5. Problems and solutions
Gastrointestinal tract of food animals is an anaerobic
environment where E. coli O157:H7, a facultatively anaerobic
organism, can survive and grow, however, under tight competition
with the gut normal ﬂora. Bacteriophage proliferation is dependent
on its host growth rate and it does not take place in non-growing
host cells. Also, the ability of the phages to adapt to, and proliferate,
under anaerobic conditions should also be taken under
consideration. Indeed, it was shown that aeration was important
for the elimination of bacteria by the phages from in vitro cultures.
In non-aerated samples, bacteria were eliminated only after 5 days
and at 4 °C (Kudva et al., 1999; Rivas et al., 2010). Only a few phages
have been found to be effective under anaerobic conditions, such as a
cocktail of phages EP16, PP17, SP22 that signiﬁcantly decreased the
E. coli O157:H7 numbers in anaerobic condition (Kunisaki and
Tanji, 2010).
The main problem in oral application of phages is acidity and
proteolytic activity of the stomach (Ryan et al., 2011). Most phages
are acid-sensitive and cannot tolerate acidic conditions of stomach.
Koo et al. used antacid with vibriophages and proposed that antacids
increase phage survival in stomach (Koo et al., 2001). Smith et al.
used CaCO3 to protect phage from stomach acidity (Smith et al.,
1987). Also, the cocktail which Tanji used was not stable at acidic
pH, so CaCO3 was used to prepare the cocktail (Tanji et al., 2005).
Microencapsulation of phage particles in polymers could also be a
suitable method to increase phage viability. Chitosan-Alginate
microencapsulated Felix O1 (a Salmonella phage) survived much
better than free phage under conditions simulating pig
gastrointestinal tract (Ma et al., 2008). Stanford et al. used phages
rV5, wV7, wV8, and wV11 as a cocktail in methacrylate polymer.
The encapsulation was effective in protecting phages from pH of 3
in vitro. However, when used in cattle, the encapsulated phages did
not reduce E. coli O157 shedding in feces, but reduced the shedding
period (Stanford et al., 2010). It is recommended in all phage therapy
experiments to use a cocktail of phages with different host ranges
and different receptors on host to broaden the host range and reduce
occurrence of phage resistance in the target organisms (Tanji et al.,
2005; Tanji et al., 2004).
56 S. Sabouri et al. / International Journal of Food Microbiology 243 (2017) 52–576. Conclusions
The isolated phages against pathogenic bacterium E. coli O157:H7
were effective in eliminating or decreasing the number of bacteria in
vitro. However, in vivo experiments did not demonstrate such clear
efﬁciency. There are several problems using phages orally and
pharmaceutical sciences could introduce novel strategies to solve
these problems. The work should be continued as more efﬁcient
phage treatment regimens might be found in future. In addition, more
studies should be focused on ﬁnding active phages in digestive system
pH and anaerobic conditions.
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